FDA
- Status: approved
Oral tablet and transdermal patch (Oral tablet and transdermal patch) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
B.P. Koirala Institute of Health Sciences is the originator. The local marketing authorisation holder may differ — check the official source linked above.